Renowned scientist Dr. Mariano Barbacid is on the verge of securing the €3.5 million needed to continue groundbreaking research in the fight against pancreatic cancer, one of the deadliest forms of cancer worldwide.
Dr. Barbacid, a pioneer in cancer genetics, has dedicated years to studying the molecular mechanisms behind tumor development. His work has been instrumental in advancing scientific understanding of how cancer cells grow and spread, opening doors to more targeted and effective treatments.
The funding campaign, which has drawn support from institutions, organizations, and individual donors, aims to accelerate research focused on improving survival rates and developing innovative therapies for pancreatic cancer patients.
With limited treatment options and a low survival rate, pancreatic cancer remains one of the most challenging diseases to treat. Dr. Barbacid’s near-success in reaching this funding milestone represents a major step forward in the global effort to combat the illness and bring hope to millions of patients and families worldwide.
“A major step forward in cancer research—Dr. Barbacid is close to securing €3.5M to advance the fight against pancreatic cancer.”
